Tumors of the immunocompromised patient.
Immunocompromised patients are prone to develop certain malignancies, particularly involving cells of the immune system itself (1-3). In this chapter we describe the various neoplasms, note the differences between these and similar cancers in the general population, emphasize similar tumor patterns in different types of immunodeficiency, and discuss possible etiologic factors.
Penn
I
I
Department of Surgery, University of Cincinnati Medical Center, Ohio 45267.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000970:Antineoplastic Agents / Q000009:adverse effects; D006801:Humans; D007108:Immune Tolerance; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008048:Lip Neoplasms / Q000209:etiology; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology; D009369:Neoplasms / Q000209:etiology*; D012514:Sarcoma, Kaposi / Q000209:etiology; D012878:Skin Neoplasms / Q000209:etiology
D000970:Antineoplastic Agents